definiens: as that term is defined in 21 C.F.R. § 314 . 3(b ) to any and all regulatory filings, data and information within the Inspire Technology relating to the Compound or Subject Products, including without limitation that related to pharmacology, to xicology, preclinical testing, clinical testing, ch emistry, manufacturing and controls data, batch records, tri als and studies, safety and efficacy, manufacturing information, analytical and quality control, and ag rees to sign, and cause its Affiliates to sign, any instruments reasonably requested by Faes in order t o effect such 17 * [ NOTE : CERTAIN PORTIONS OF THIS DOCUMENT HAVE BEEN MARKED TO INDICATE THAT CONFIDENTIAL INFORMATION HAS BEEN OMITTED . CON FIDENTIAL TREATMENT HAS BEEN REQUESTED FOR THIS CONFIDENTIAL INFORMATIO N. THE CONFIDENTIAL PORTIONS HAVE BEEN PROVIDED SEPARATELY TO THE SECUR ITIES AND EXCHANGE COMMISSION . ] grant, solely for the purposes of developing and se eking regulatory approval outside the Inspire Princ ipal Territory of Faes Non - Ophthalmic Products and/or of the Faes Licensed Ophthalmic Products in the applicable countries of the Faes Ophthalmic Territo ry as contemplated by this Agreement, and of conducting such other activities as are contemplate d by this Agreement